MENU
PMN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ProMIS Neurosciences (PMN) Earnings Date & Reports

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA)... Show more

A.I. Advisor
published Earnings

PMN is expected to report earnings to fall 12.50% to -20 cents per share on April 06

ProMIS Neurosciences PMN Stock Earnings Reports
Q4'25
Est.
$-0.21
Q3'25
Est.
$-0.24
Q2'25
Missed
by $0.13
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.28
The last earnings report on November 12 showed earnings per share of -23 cents, meeting the estimate of -23 cents. With 446.10K shares outstanding, the current market capitalization sits at 21.27M.
View a ticker or compare two or three
PMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PMN showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com